NCT05810844

Brief Summary

To determine the comparison between effects of Motor Relearning Program (MRP) and Neuro-Development Treatment (NDT) on balance and gait in chronic ischemic stroke patients.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable stroke

Timeline
Completed

Started Apr 2023

Shorter than P25 for not_applicable stroke

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 15, 2023

Completed
17 days until next milestone

Study Start

First participant enrolled

April 1, 2023

Completed
11 days until next milestone

First Posted

Study publicly available on registry

April 12, 2023

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2023

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2023

Completed
Last Updated

April 12, 2023

Status Verified

March 1, 2023

Enrollment Period

2 months

First QC Date

March 15, 2023

Last Update Submit

March 31, 2023

Conditions

Stroke

Outcome Measures

Primary Outcomes (1)

  • Effects of Motor Relearning Program Techinique, Neuro Development Treatment Techinique

    6 Months

Study Arms (2)

Motor Relearning Program (MRP)

EXPERIMENTAL
Diagnostic Test: Motor Relearning Program (MRP)

Neuro Development Treatment (NDT)

EXPERIMENTAL
Diagnostic Test: Neuro Development Treatment (NDT)

Interventions

Motor Relearning Program (MRP)DIAGNOSTIC_TEST

MRP technique with a conventional physiotherapy treatment. Conventional physiotherapy treatment will help to reduce the functional impairments in chronic ischemic stroke

Motor Relearning Program (MRP)
Neuro Development Treatment (NDT)DIAGNOSTIC_TEST

Neuro-Development Treatment NDT as well as conventional treatment. Conventional physiotherapy treatment will help to reduce the functional impairments in chronic ischemic stroke patients

Neuro Development Treatment (NDT)

Eligibility Criteria

Age45 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Chronic ischemic stroke Patients more than 6 months. (55)
  • Patient with good cognitive status minimum 20 or greater out of 30 in Mini mental state examinations.(56)
  • Age between 45-65 years.(57)
  • Patient with limb spasticity equal to 2 or less than 2 on Modified Ashworth scale.(56)
  • Both male and female patients.(58)

You may not qualify if:

  • History of neurologic disease(59, 60)
  • History of lower limb fracture.(61)
  • History of spinal cord fracture.(61)
  • Patient with skin discoloration, skin ulcers and skin allergy.(62)
  • Patients with a history of the recurrent stroke. (63)
  • Patients with any peripheral vascular disease.(60)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

March 15, 2023

First Posted

April 12, 2023

Study Start

April 1, 2023

Primary Completion

June 1, 2023

Study Completion

August 31, 2023

Last Updated

April 12, 2023

Record last verified: 2023-03

Data Sharing

IPD Sharing
Will not share